Po-316 Isoquercetin: A Novel Agent to Increases Vash1 and Suppress Colon Cancer

doi 10.1136/esmoopen-2018-eacr25.829
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd

Related search

Molecular Targeting of Protein Arginine Deiminases to Suppress Colitis and Prevent Colon Cancer

Oncotarget
Oncology
2015English

Synbiotics Suppress Colitis-Induced Tumorigenesis in a Colon-Specific Cancer Mouse Model

PLoS ONE
Multidisciplinary
2019English

miR-126: A Novel Regulator in Colon Cancer

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2015English

Largazole as a Novel and Selective Anti-Breast Cancer Agent

2011English

300 GTP-cyclohydrolase I Increases by Aging to Suppress the Oxidative Stress Induced Human Nonmelanoma Skin Cancer

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Leptin and Insulin Up-Regulate miR-4443 to Suppress NCOA1 and TRAF4, and Decrease the Invasiveness of Human Colon Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

P53 Gene Mutation Increases Progastrin Dependent Colonic Proliferation and Colon Cancer Formation in Mice

Cancer Investigation
MedicineCancer ResearchOncology
2012English

Liver Receptor Homologue 1, a Novel Prognostic Marker in Colon Cancer Patients

Oncology Letters
Cancer ResearchOncology
2018English

Salinomycin: A Novel Anti-Cancer Agent With Known Anti-Coccidial Activities

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy